ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintSite TitleTitle ChevronIcon Twitter
Health Technology

Olympus Corp.

Business Summary

Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. The Scientific Solutions segment manufactures and sells biological and industrial microscopes, industrial endoscopes, and non-destructive testing equipment. The Imaging segment deals with digital cameras and recording devices. The Others segment includes biomaterial manufacturing and sales business. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.

Financial Highlights

Mar 2020 JPYUSD
Revenue797,411M7,334.14M
Gross Profit461,235M4,242.18M
Operating income94,544M869.56M
Income before tax77,798M715.54M
Net income51,670M475.23M
EBITDA162,853M1,497.83M
Diluted EPS39.350.36
Dividends Per Share100.09
Total Assets1,015.66B9,408.20M
Total liabilities643,705M5,962.71M
Total equity370,747M3,434.27M
Operating cash flow133,544M1,228.26M
Currency in JPYCurrency in USD

Historical Data

 Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Revenue 804,578M 740,557M 786,497M 793,862M 797,411M
Gross Profit 534,482M 447,567M 481,111M 479,699M 461,235M
Operating income 104,464M 80,789M 84,282M 72,171M 94,544M
Income before tax 70,800M 62,481M 76,665M 20,117M 77,798M
Net income 62,594M 42,783M 57,064M 8,147M 51,670M
EBITDA 154,243M 135,079M 137,195M 130,840M 162,853M
Diluted EPS 45.71 31.24 41.69 5.96 39.35
Dividends Per Share 4.25 7 7 7.50 10
Total Assets 1,000.61B 960,032M 978,663M 932,030M 1,015.66B
Total liabilities 616,331M 563,804M 534,404M 489,643M 643,705M
Total equity 382,787M 394,751M 442,793M 441,193M 370,747M
Operating cash flow 48,621M 102,052M 95,146M 66,943M 133,544M
 Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Revenue 6,700.11M 6,838.80M 7,096.27M 7,158.70M 7,334.14M
Gross Profit 4,450.89M 4,133.13M 4,340.88M 4,325.71M 4,242.18M
Operating income 869.92M 746.06M 760.44M 650.80M 869.56M
Income before tax 589.58M 576.99M 691.71M 181.40M 715.54M
Net income 521.25M 395.08M 514.86M 73.46M 475.23M
EBITDA 1,284.45M 1,247.41M 1,237.85M 1,179.85M 1,497.83M
Diluted EPS 0.38 0.28 0.37 0.05 0.36
Dividends Per Share 0.03 0.06 0.06 0.06 0.09
Total Assets 8,902.65M 8,615.56M 9,202.28M 8,420.56M 9,408.20M
Total liabilities 5,483.61M 5,059.71M 5,024.95M 4,423.75M 5,962.71M
Total equity 3,405.72M 3,542.59M 4,163.54M 3,986.02M 3,434.27M
Operating cash flow 404.89M 942.41M 858.46M 603.66M 1,228.26M

Valuation Measures

Mar 2020
PER39.67
ROA5.30%
ROE12.72%
Operating margin11.85%
Profit margin6.47%

Key executives

  • President, Chief Executive Officer & Director: Yasuo Takeuchi
  • Chief Operating Officer: Nacho Abia
  • Chief Financial Officer: Chikashi Takeda
  • Chief Technology Officer: Akihiro Taguchi
  • Chief Information Security Officer: Masahito Kitamura

Shareholders

  • Olympus Corp. (6.2%)
  • ValueAct Capital Management LP (5.0%)
  • Nomura Asset Management Co., Ltd. (4.8%)
  • Massachusetts Financial Services Co. (3.9%)
  • Nippon Life Insurance Co. (3.8%)
  • Sumitomo Mitsui Banking Pension Fund (3.3%)
  • Mitsubishi UFJ Financial Group, Inc. (3.2%)
  • Nikko Asset Management Co., Ltd. (2.7%)
  • Daiwa Asset Management Co. Ltd. (2.5%)
  • Sumitomo Mitsui Trust Asset Management Co., Ltd. (2.3%)

Contact Details

  • Website:http://www.olympus.co.jp
  • Address: Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Tokyo, 163-0914, Japan
  • Phone: +81.3.3340.2111

Related Companies

  • Olympus Memory Works Corp.
  • TmediX Corp.
  • Olympus Medical Science Sales Corp.
  • Olympus System Co., Ltd.
  • Olympus Singapore Pte Ltd.
  • Olympus Restricted Stock Compensation Plan
  • YuanLi Instrument Co. Ltd.
  • Olympus Service Facility Portugal - Tecnologias Opticas e Digi
  • Olympus Korea Service Co., Ltd.
  • Olympus Optical do Brasil Ltda.
  • Olympus Moscow LLC
  • Olympus Europa SE & Co. KG
  • Olympus Europa Property Management GmbH
  • Olympus doo za trgovinu
  • Olympus Corporation of the Americas Pennsylvania
  • Olympus doo Beograd
  • Olympus Czech Group sro
  • Olympus Slovenija Trgovina doo
  • Olympus Iberia SAU
  • Olympus Communications Technology of America, Inc.
  • Vichen B&I Co., Ltd.
  • Gyrus ACMI, Inc.
  • Olympus Estonia OU
  • Olympus (Thailand) Co. Ltd.
  • Olympus Australia Pty Ltd.
  • Olympus Europa Management SE
  • Olympus BH doo
  • Olympus Medical Systems Vietnam Co. Ltd.
  • Olympus Schweiz AG
  • Olympus Canada, Inc.

Competitors

  • CONMED Corporation
  • Stryker Corporation
  • Mauna Kea Technologies SA Class O
  • Merit Medical Systems, Inc.
  • IntroMedic Co., Ltd.
  • Cantel Medical Corp.
  • STERIS Plc
  • Baker Hughes Company Class A
  • Cooper Companies, Inc.
  • Check-Cap Ltd.
  • Kinko Optical Co. Ltd.
  • Motus GI Holdings, Inc.
  • Apollo Endosurgery, Inc.
  • Bruker Corporation
  • Intersect ENT Inc
  • Intuitive Surgical, Inc.
  • Vuzix Corporation
Last Updated on 1 Jun, 2020

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Get Unlimited access

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends April 30th

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media